Pharmaceutical industry

B.C. scraps controversial plan to involuntarily treat youth after overdose

Roche warns multiple sclerosis drug development hit by Ukraine war

Ottawa dropped some drug pricing reforms to meet need for ‘strong’ pharmaceutical industry, Health Minister says

Lessons from the pandemic: Adam Tooze on what COVID teaches us – and what we have failed to learn

Dozens of firms to make cheap version of Merck COVID-19 pill for poorer nations

U.S. court bars Martin Shkreli from pharmaceutical industry, orders him to return $64.6-million

For fourth time, Ottawa delays new drug-pricing regulation

U.S. President Joe Biden will nominate industry-friendly Robert Califf to lead FDA

Novavax submits COVID-19 vaccine for approval by Health Canada

Ottawa delays drug-pricing changes a third time, citing COVID-19 pandemic

Canada is missing out on global pharma boom, and things are about to get worse

Drug makers want another delay for new pricing regulations from Ottawa

Is Ottawa prepared to call Big Pharma’s bluff?

Canadian maker of promising mRNA COVID-19 vaccine looks to test it against Pfizer in new trial

Bausch Health selling stake in Egypt’s Amoun for $740-million

Small cap to watch: Why this Montreal-based pharma stock is up 12% in the past 3 trading days

A booster shot for Big Pharma’s chronic productivity condition: give up sooner

EU regulators team up with U.S. and U.K. on pharmaceutical mergers

Why is Justin Trudeau cutting off his nose to spite Big Pharma?

McKinsey’s top executive voted out as consulting firm faces reckoning over opioid crisis

Bausch Health shareholder pushes for completion of eye-care spinoff by end of 2021

GSK forecasts dip in profit but says plan to split business still on track

Investors flock to Canadian device maker Sernova hoping to transform how diabetes is treated

Bausch Health expects 2020 revenue to exceed previous guidance

Regulations to lower drug prices in Canada delayed yet again after industry cites COVID-19 concerns

Merck signs $356-million U.S. supply deal for experimental COVID-19 treatment

Canopy Growth cuts ties with investment company Canopy Rivers

Newly approved treatment could save a young child in Edmonton with a rare disease. It costs $2.8-million per dose

Merck sells stake in vaccine developer Moderna

Ottawa blocks Trump plan to allow bulk U.S. import of cheaper prescription drugs from Canada

The credibility of pharmaceutical companies is on the line. Will they get it right?

Trump makes late-term bid to lower prescription drug costs

Pharmaceutical industry offers Ottawa $1-billion to scrap pending drug pricing rules, documents show

Developing a coronavirus vaccine is just the first step – distribution presents a whole new challenge